Cardiovascular Drugs Market Increase in Value Share During the Forecast Period

Posted by vamshi krishna on June 12th, 2019

The cardiovascular drugs market consists of sales of cardiovascular drugs and related services by entities (organizations, sole traders and partnerships) that produce cardiovascular drugs to treat cardiovascular diseases. This industry includes establishments that produce anti-hypertensive drugs to prevent heart failure by controlling blood pressure and hypolipidemic drugs that reduce lipid and lipoprotein levels in the blood. It also consists of establishments which produce antithrombotic drugs to treat arterial and venous thrombosis.

The cardiovascular drugs market expected to reach a value of nearly .67 billion by 2022, significantly growing at a CAGR of 1.2% during the forecast period. The growth in the Cardiovascular drugs market is due to increase in aging population, increase in the prevalence of cardiovascular diseases and availability of more generic drugs that reduce the cost of treatment.

View complete Report: https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report       

NOACs are gaining wider acceptance and are replacing traditionally used anti-coagulants such as Warfarin and Heparin. Anti-coagulants have long been used in prevention of thrombus formation in patients suffering with cardiovascular diseases. Use of NOACs makes it easier for patients to continue therapy post discharge as opposed to injections of Heparin and Warfarin which need medical assistance for administration. Some of the NOACs include Pradaxa (dabigatran etexilate) from Boehringer Ingelheim, Xarelto (rivaroxaban) from Janssen, and Eliquis (apixaban) from Bristol-Myers Squibb.

The global cardiovascular drugs is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, Asia Pacific was the largest region in the global cardiovascular drugs market.

Request a Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=2134&type=smp       

Table Of Content

1. Executive Summary

2. Report Structure

3. Cardiovascular Drugs Market Characteristics

4. Cardiovascular Drugs Market Product Analysis

5. Cardiovascular Drugs Market Supply Chain

6. Cardiovascular Drugs Market Customer Information

7. Cardiovascular Drugs Market Trends And Strategies

8. Cardiovascular Drugs Market Size And Growth

9. Cardiovascular Drugs Market Regional Analysis

10. Cardiovascular Drugs Market Segmentation

11. Cardiovascular Drugs Market Metrics

12. Asia-Pacific Cardiovascular Drugs Market

13. Western Europe Cardiovascular Drugs Market

14. Eastern Europe Cardiovascular Drugs Market

15. North America Cardiovascular Drugs Market

16. South America Cardiovascular Drugs Market

17. Middle East Cardiovascular Drugs Market

18. Africa Cardiovascular Drugs Market

19. Cardiovascular Drugs Market Competitive Landscape

20. Key Mergers And Acquisitions In The Cardiovascular Drugs Market

21. Market Background: Pharmaceutical Drugs Market

22. Recommendations

23. Appendix

24. Copyright And Disclaimer          

About Us:

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293